Floatz logo

42 assets in Acute Biphenotypic Leukemia

Therapeutic assets addressing Acute Biphenotypic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3BB (71)
Cytarabine
Acute Biphenotypic Leukemia
University of WashingtonP2BB (70)
Nivestim
Acute Biphenotypic Leukemia
Ossium Health, Inc.P2BB (70)
Busulfanum
Acute Biphenotypic Leukemia
Ossium Health, Inc.P2BB (69)
Cyclophosphamide
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP3BB (68)
Thiotepa
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP2BB (68)
Cladribine
Acute Biphenotypic Leukemia
University of WashingtonP2BB (67)
Tacrolimus
Acute Biphenotypic Leukemia
St. Petersburg State Pavlov Medical UniversityP3BB (66)
Melphalan
Acute Biphenotypic Leukemia
H. Lee Moffitt Cancer Center and Research InstituteP2BB (65)
Rituximab
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2BB (65)
Treosulfan
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3BB (65)
Clofarabine
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2BB (64)
Idarubicin
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2BB (64)
Venetoclax
Acute Biphenotypic Leukemia
University of WashingtonP2BB (64)
Abatacept Recombinant
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP3B (63)
Methotrexate
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP3B (62)
Sirolimus
Acute Biphenotypic Leukemia
Masonic Cancer Center, University of MinnesotaP2B (60)
Azacitidine
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2B (57)
Bendamustine
Acute Biphenotypic Leukemia
St. Petersburg State Pavlov Medical UniversityP2B (57)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2B (56)
Vedolizumab
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP3B (56)
Baricitinib
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3CCC (55)
Etoposide
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3CCC (55)
Mitoxantrone
Acute Biphenotypic Leukemia
University of WashingtonP1/2CCC (54)
Allopurinol
Acute Biphenotypic Leukemia
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Cedazuridine
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Decitabine
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Enasidenib
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Gilteritinib
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Midostaurin
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
NK-92
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Retinol
Acute Biphenotypic Leukemia
St. Petersburg State Pavlov Medical UniversityP2CCC (53)
Ruxolitinib
Acute Biphenotypic Leukemia
St. Petersburg State Pavlov Medical UniversityP2CCC (53)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Dilanubicel
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP2CCC (48)
Quizartinib
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Recombinant Human Granulocyte Colony-Stimulating Factor
Acute Biphenotypic Leukemia
University of WashingtonP1/2CC (47)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes
Acute Biphenotypic Leukemia
City of Hope Medical CenterP1CC (43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Acute Biphenotypic Leukemia
City of Hope Medical CenterP1CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP1CC (43)
Mesna
Acute Biphenotypic Leukemia
Ossium Health, Inc.P1CC (43)
Selinexor
Acute Biphenotypic Leukemia
Dana-Farber Cancer InstituteP1CC (43)